Dr. Fisher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365 Clifton Rd, Building A
Suite A3229
Atlanta, GA 30322Phone+1 404-778-3261Fax+1 404-778-4431
Education & Training
- Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2002
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1999
Certifications & Licensure
- GA State Medical License 2005 - 2025
- MD State Medical License 2003 - 2006
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI) Start of enrollment: 2009 Jan 01
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
- An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 Sep 11
- Join now to see all
Publications & Presentations
PubMed
- 678 citationsAccuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.Micah R. Fisher, Paul R. Forfia, Elzbieta Chamera, Traci Housten-Harris, Hunter C. Champion
American Journal of Respiratory and Critical Care Medicine. 2009-04-01 - 48 citationsCombination therapy with oral treprostinil for pulmonary arterial hypertension: A double-blind placebo-controlled clinical trialR. James White, Carlos Jerjes-Sánchez, Gisela Martina Bohns Meyer, Tomas Pulido, Pablo Sepúlveda
American Journal of Respiratory and Critical Care Medicine. 2020-03-15 - 22 citationsSafety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.Adaani E. Frost, Munir Janmohamed, Jason S. Fritz, John W. McConnell, David Poch
The Journal of Heart and Lung Transplantation. 2019-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: